GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » TheraCryf PLC (LSE:TCF) » Definitions » Inventory-to-Revenue

TheraCryf (LSE:TCF) Inventory-to-Revenue : 0.00 (As of Sep. 2024)


View and export this data going back to 2015. Start your Free Trial

What is TheraCryf Inventory-to-Revenue?

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. TheraCryf's Average Total Inventories for the quarter that ended in Sep. 2024 was £0.00 Mil. TheraCryf's Revenue for the six months ended in Sep. 2024 was £0.00 Mil.

TheraCryf's Inventory-to-Revenue for the quarter that ended in Sep. 2024 stayed the same from Mar. 2024 (0.00) to Mar. 2024 (0.00)

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Inventory Turnover measures how fast the company turns over its inventory within a year.


TheraCryf Inventory-to-Revenue Historical Data

The historical data trend for TheraCryf's Inventory-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

TheraCryf Inventory-to-Revenue Chart

TheraCryf Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Inventory-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

TheraCryf Semi-Annual Data
Mar15 Sep15 Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24
Inventory-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of TheraCryf's Inventory-to-Revenue

For the Biotechnology subindustry, TheraCryf's Inventory-to-Revenue, along with its competitors' market caps and Inventory-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


TheraCryf's Inventory-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, TheraCryf's Inventory-to-Revenue distribution charts can be found below:

* The bar in red indicates where TheraCryf's Inventory-to-Revenue falls into.



TheraCryf Inventory-to-Revenue Calculation

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

TheraCryf's Inventory-to-Revenue for the fiscal year that ended in Mar. 2024 is calculated as

Inventory-to-Revenue (A: Mar. 2024 )
=Average Total Inventories / Revenue
=( (Total Inventories (A: Mar. 2023 ) + Total Inventories (A: Mar. 2024 )) / count ) / Revenue (A: Mar. 2024 )
=( (0 + 0) / 1 ) / 0.396
=0 / 0.396
=0.00

TheraCryf's Inventory-to-Revenue for the quarter that ended in Sep. 2024 is calculated as

Inventory-to-Revenue (Q: Sep. 2024 )
=Average Total Inventories / Revenue
=( (Total Inventories (Q: Mar. 2024 ) + Total Inventories (Q: Sep. 2024 )) / count ) / Revenue (Q: Sep. 2024 )
=( (0 + 0) / 1 ) / 0
=0 / 0
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


TheraCryf  (LSE:TCF) Inventory-to-Revenue Explanation

An increase in Inventory-to-Revenue from one quarter to the next indicates that one of the following is happening:

1. investment in inventory is growing more rapidly than revenue
2. revenue are dropping
No matter which situation is causing the problem, an increase in the Inventory-to-Revenue may signal an oncoming cash flow problem.

Likewise, a decrease in the Inventory-to-Revenue from one quarter to next indicates that one of these is occurring:

1. investment in inventory is shrinking in relation to revenue
2. revenue are increasing
No matter which situation is causing the reduction in the Inventory-to-Revenue, either one suggests that business's inventory levels and its cash flow are effectively managed.

More Related Terms:

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

TheraCryf's Days Inventory for the six months ended in Sep. 2024 is calculated as:

Days Inventory=Average Total Inventories (Q: Sep. 2024 )/Cost of Goods Sold (Q: Sep. 2024 )*Days in Period
=0/0*365 / 2
=

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

TheraCryf's Inventory Turnover for the quarter that ended in Sep. 2024 is calculated as

Inventory Turnover=Cost of Goods Sold (Q: Sep. 2024 ) / Average Total Inventories (Q: Sep. 2024 )
=0 / 0
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


TheraCryf Inventory-to-Revenue Related Terms

Thank you for viewing the detailed overview of TheraCryf's Inventory-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


TheraCryf Business Description

Traded in Other Exchanges
Address
Congleton Road, Alderley Park, Nether Alderley, Cheshire, GBR, SK10 4TG
TheraCryf PLC is a clinical-stage biotechnology company focused on profitable segments in oncology and neuropsychiatry. The company's lead clinical asset, SFX-01 is a patented form of delivering sulforaphane, which could be used in the treatment of a number of cancers, neurodevelopmental disorders, and other diseases.